BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4542777)

  • 1. Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b.
    Smith DH; Peter G; Ingram DL; Harding AL; Anderson P
    Pediatrics; 1973 Nov; 52(5):637-44. PubMed ID: 4542777
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response.
    O'Reilly RJ; Anderson P; Ingram DL; Peter G; Smith DH
    J Clin Invest; 1975 Oct; 56(4):1012-22. PubMed ID: 1099117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Background and indications for Haemophilus influenzae type b vaccines consisting of capsular antigen coupled to protein carriers.
    Anderson PW; Stein EC; Insel RA
    Contrib Microbiol Immunol; 1989; 10():115-24. PubMed ID: 2684504
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory.
    Käyhty H; Karanko V; Peltola H; Mäkelä PH
    Pediatrics; 1984 Nov; 74(5):857-65. PubMed ID: 6387614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of previous infection on antibody response of children to vaccination with capsular polysaccharide of Haemophilus influenzae Type b.
    Norden CW; Michaels RH; Melish M
    J Infect Dis; 1975 Jul; 132(1):69-74. PubMed ID: 1080178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophilus influenzae, type b, antibody frequencies determined with bactericidal and radioimmunoassay tests.
    Norden CW; Feldman HA
    J Clin Microbiol; 1976 Aug; 2(2):136-8. PubMed ID: 1085776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to disease caused by Hemophilus influenzae type b. II. Specificity and some biologic characteristics of "natural," infection-acquired, and immunization-induced antibodies to the capsular polysaccharide of Hemophilus influenzae type b.
    Schneerson R; Rodrigues LP; Parke JC; Robbins JB
    J Immunol; 1971 Oct; 107(4):1081-9. PubMed ID: 5315273
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vaccine based on the capsular polysaccharide of Haemophilus influenzae type b].
    Poolman JT; Rijkers GT
    Ned Tijdschr Geneeskd; 1988 Sep; 132(38):1737-40. PubMed ID: 3262833
    [No Abstract]   [Full Text] [Related]  

  • 9. Host factors and antibody response Haemophilus influenza type b meningitis and epiglottitis.
    Whisnant JK; Rogentine GN; Gralnick MA; Schlesselman JJ; Robbins JB
    J Infect Dis; 1976 Apr; 133(4):448-55. PubMed ID: 1083399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemophilus influenzae b meningitis in identical twins of a triplet sibship.
    Coulter D; Whisnant JK; Marks MI
    Pediatrics; 1974 Oct; 54(4):502-4. PubMed ID: 4547219
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies.
    Robbins JB; Parke JC; Schneerson R; Whisnant JK
    Pediatr Res; 1973 Mar; 7(3):103-10. PubMed ID: 4120458
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prospects for the vaccinal prevention of Haemophilus influenzae type b meningitis].
    Armand J
    Pathol Biol (Paris); 1983 Feb; 31(2):144-8. PubMed ID: 6341945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polysaccharide vaccine for prevention of haemophilus influenzae type B disease. 1.
    Ky Nurse; 1985; 33(4):18-9. PubMed ID: 3875002
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of IgG antipolyribosylribitolphosphate antibodies in the course of H. influenzae type b meningitis in infants below 2 years of age.
    Rijkers GT; Roord JJ; Struyvé MC; Poolman JT; Zegers BJ
    Monogr Allergy; 1988; 23():282-8. PubMed ID: 3260338
    [No Abstract]   [Full Text] [Related]  

  • 15. Further studies on the immunology of the infant rat experimental model of Haemophilus influenzae type B meningitis.
    Myerowitz RL; Norden CW
    Br J Exp Pathol; 1978 Oct; 59(5):544-50. PubMed ID: 309766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic tritium labeling of the capsular polysaccharide antigen of Haemophilus influenzae type B.
    Anderson P
    J Immunol; 1978 Mar; 120(3):866-70. PubMed ID: 75930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of the quantification of capsular antigens of haemophilus influenzae type b in the cerebrospinal fluid].
    Valvano MA; Grinstein S
    Medicina (B Aires); 1982; 42(5):475-82. PubMed ID: 6984876
    [No Abstract]   [Full Text] [Related]  

  • 18. An Escherichia coli antigen cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b: occurrence among known serotypes, and immunochemical and biologic properties of E. coli antisera toward H. influenzae type b.
    Schneerson R; Bradshaw M; Whisnant JK; Myerowitz RL; Parke JC; Robbins JB
    J Immunol; 1972 Jun; 108(6):1551-62. PubMed ID: 4624175
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b.
    Anderson P; Peter G; Johnston RB; Wetterlow LH; Smith DH
    J Clin Invest; 1972 Jan; 51(1):39-44. PubMed ID: 4536615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity with Escherichia coli K100 in the human serum anticapsular antibody response to Haemophilus influenzae type B.
    Insel RA; Anderson PW
    J Immunol; 1982 Mar; 128(3):1267-70. PubMed ID: 7035561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.